Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Marker Therapeutics (MRKR) Other Non Operating Income (2016 - 2025)

Marker Therapeutics (MRKR) has disclosed Other Non Operating Income for 7 consecutive years, with $117444.0 as the latest value for Q2 2025.

  • Quarterly Other Non Operating Income changed N/A to $117444.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $117444.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $117444.0 for FY2025, N/A changed from the prior year.
  • Other Non Operating Income for Q2 2025 was $117444.0 at Marker Therapeutics, up from $31000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $117444.0 in Q2 2025, with the low at $117444.0 in Q2 2025.